© Copyright Nostre Net
Urinalysis
Test Market Size was valued at USD 2.5 billion in 2022 and is projected to
grow from USD 2.6875 Billion in 2023 to USD 4.147 billion by 2030, exhibiting a
compound annual growth rate (CAGR) of 7.50% during the forecast period (2023 -
2030).The increased demand for point of care testing devices is likely to favor
the market growth. Urinalysis is referred to as a urine test which is performed
to detect and manage disorders like liver disease, urinary tract infections,
diabetes, and kidney disease. A cost-effective and non-invasive analysis
method, urinalysis involves checking the content, appearance, and concentration
of the urine. These kinds of tests are highly recommended during a routine
examination, pregnancy checkup, and pre-surgery preparation in order to detect
any disease condition.
Market Potential and Pitfalls
The urinalysis market is growing at
breakneck speed due to the rising demand for point of care testing devices,
developing technologies in the field of diagnostics, and increased prevalence
of chronic diseases across the globe. The cost-effectiveness along with the
augmenting demand for urine automated urine analyzers are acting as push
factors for the growth of the market. As per the National Institute of Diabetes
and Digestive and Kidney Diseases, the prevalence of chronic kidney disease
among the general population is about 14%. The urinalysis market has undergone
several technological advancements which are further anticipated to boost the
market across the globe as such advancements have proved to improve the
reliability and efficiency of the results. Moreover, urine analyzers are
integrated with Electronic Health Records in order to link the results directly
into the database of the patient. Siemens AG has collaborated with Relaymed in
order to bring labs cloud-based connectivity for Clinitek Status POC
instruments and the Siemens DCA Vantage analyzer. With the change in lifestyle
and increasing incidences of chronic diseases, there is an increased demand for
advanced and quick tests, which has further resulted in the growth of the
market.
Competitive Dashboard
The prominent players operating in the
urinalysis test market are Dahaner (U.S.), ARKRAY Inc. (Japan), F. Hoffmann-La
Roche Ltd (Switzerland), Sysmex Corporation (Japan), Siemens AG (U.S.), Bio-Rad
Laboratories Inc. (U.S.), and ACON Laboratories Inc. (U.S.).
Global Urinalysis Test Market:
Segmental Analysis
The global urinalysis
test market Insights has been segmented on the basis of test type, product
type, end user, and application.
By mode of product type, the global
urinalysis test market has been segmented into consumables and instruments.
Among these, the consumables are expected to hold a significant share in the
global market owing to its extensive use in the disposables in urinalysis
research and testing. Moreover, the advent of advanced reagents and use of
disposables are likely to favor the growth of the segment.
By mode of test type, the global urinalysis
test market has been segmented into biochemical urinalysis, macroscopic
urinalysis, urinalysis analyzer and sediments/microscopic urinalysis. Among
these, the biochemical urinalysis is likely to occupy a significant share owing
to the rapidly increasing geriatric population coupled with the increased
incidences of kidney diseases and urinary tract infections.
Regional Insights
Geographically, the urinalysis test market
span across regions namely, Europe, America, Asia Pacific, and the Middle East
& Africa.
Considering the global scenario, America is
considered to occupy the largest market share due to the increased demand for
automated urine analyzers, accelerating incidences of liver and kidney diseases,
and technological advancements in this region. In the North American region,
the U.S. is estimated to hold the major share due to the high concentration of
market giants manufacturing consumables and urine analyzers.
About US:
Market Research Future (MRFR), enable customers to
unravel the complexity of various industries through Cooked Research Report
(CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R),
Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Healthcare
Enterprise Software Market size is anticipated to reach USD 28,580 Million
by 2030 at 14.50% CAGR during the forecast period 2022-2030.Healthcare software
is used by nursing homes and hospitals for managing data both clinical and
non-clinical. It helps in maintaining patient records electronically resulting
in hassle-free storage and retrieval. Such software aids in managing, securing
and analyzing information precisely in healthcare environment. Ample data can
be stored here rather than handling records manually.
There are abundant factors that is
propelling the growth of the healthcare enterprise software market. These
factors as per the MRFR (Market Research Future) report include increase in
software solutions available exclusively for healthcare management, increasing
global competition, increasing awareness about enterprises software,
introduction of new software services, technological advancement and
innovation, entry of novel industry players, increasing number of enterprises
across the world, strict rule governing the patient information management and
attention on electronic health records. On the contrary, price of the software
solution is likely to impede the growth of the many healthcare facilities now
use voice recognition software for transcription.
Regional Analysis
By region, the healthcare enterprise
software market covers growth opportunities and latest trends across Americas,
Europe, Asia Pacific and Middle East and Africa. Of these, Americas will remain
the largest market over the forecast period owing to growing need for software
solutions to manage patient’s medical records coupled with increasing
utilization of information technology (IT) in hospitals. Factors that are
imparting towards the growth of the healthcare enterprise software market in
this region include extensive utilization of software solutions for healthcare
management, use of electronic records over manual records, growing significance
of electronic health records, advancement in technology in software
development, health record maintenance, awareness amid patients regarding
significance of their medical records as well as, legal applications, and
demand for software solutions that are user friendly. In the US the leading
healthcare IT and medical device companies are global leaders in offering
healthcare software solutions and manufacturing medical components and devices.
The healthcare enterprise software market in Europe will have the second major
share due to rise in use of IT for healthcare management. This market is
expanding constantly and catching up slowly with the market in North America.
In the APAC region, the healthcare enterprise software market is expected to
grow at the fastest pace owing to increasing awareness regarding the software
coupled with use of electronic records over manual records. Diagnostic devices
are showing an increasing and positive growth in the market. Toshiba Medical
Systems Corporation is one of the key market players in this region. The demand
for healthcare outreaching supplies, population growth and increasing disease
burden is driving the growth of the market in this region. On the other hand,
the healthcare enterprise software market in the Middle East and Africa is
anticipated to show a steady growth over the forecast period.
Market Segmentation
MRFR report offers a broad segmental
analysis of the healthcare
enterprise software market insights on the basis of types, mode of
delivery, applications and end users.
Based on types, it is segmented into
billing, HR management software, laboratory management software, OT management
software, scheduling software, inventory management software, patient
registration software and others.
Based on mode of delivery, the healthcare
enterprise software market is segmented into cloud base and on-premise.
Based on application, it is segmented into
non-clinical, clinical and others.
Based on end users, the healthcare
enterprise software market is segmented into pharmacy, clinics, hospitals and
others.
Key Players
Leading players profiled in the healthcare
enterprise software market include CompuGroup (UK), Medidata Solutions (US),
Athenahealth (US), Cerner Corporations (US), McKesson Corporation (US), Infosys
Ltd. (U.S), Cognizant Technology Solutions Corporation (U.S.), IBM Corporation
(U.S), Allscripts Healthcare Solutions (U.S), and Microsoft Corporation (U.S).
About US:
Market Research Future (MRFR), enable customers to
unravel the complexity of various industries through Cooked Research Report
(CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R),
Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Market Synopsis:
The fertility
drug and surgery market share is expected to reach USD 2.21 billion by 2030
at 9.50% CAGR during the forecast period 2022-2030.The rates of infertility are
getting higher, which has encouraged massive investments in the research &
development of effective drugs and surgeries. Market Research Future (MRFR) has
highlighted in its latest analysis that the global fertility drug and surgery
market is projected to expand at a CAGR of 9.8% during the projection period of
2018 to 2023.
Infertility diseases affect both men and women. Treatments
have been developed for both the genders and drug research is expected to
constantly drive the expansion of the fertility drug and surgery market over
the next couple of years. In addition, rising working population of women has
led to increased cases of late pregnancies. This, in turn, is prognosticated to
boost the revenue creation of the fertility drug and surgery market over the
next couple of years.
Obesity is also a significant factor driving the growth of
the market. Increasing burden of obesity has led to an exponential increase in
the prevalence of infertility. It is projected to catapult the global fertility
drug and surgery market on an upward trajectory over the forecast period. Other
factors such as increasing disposable income, rising healthcare expenditure,
etc. are poised to influence the market positively. However, on the flip side,
factors such as high treatment cost and complications associated with surgeries
is anticipated to restrict market growth over the next few years.
Market Segmentation:
Based on the underlying cause, the global fertility
drug and surgery market outlook has been segmented into male and female.
By drug, the fertility drug and surgery market has been
segmented into letrozole, Serophene, clomiphene citrate, hormone treatment,
gonadotrophins estrogen receptor modulators, aromatase inhibitors, dopamine
agonists, metformin hydrochloride, and others.
Depending on the procedures, the global fertility drug and
surgery market has been segmented into laparoscopy and robotic laparoscopy,
hysteroscopy, laparotomy/open surgery, varicocelectomy, vasectomy reversal
(vasovasostomy or vasoepididymostomy), egg retrieval, sperm retrieval
(epididymal aspiration).
Based on end-user, the fertility drug and surgery market has
been segmented into hospitals, clinical research institutes, fertility clinics,
and others.
Regional Analysis:
A detailed geographical analysis of the global fertility
drug and surgery market has been included in this MRFR report which covers four
major regions – Americas, Asia Pacific, Europe, and the Middle East &
Africa (MEA). Americas is likely to lead the expansion of the market on account
of the increasing rate of infertility in the region. Rising prevalence of
obesity and increasing cases of delayed pregnancies are anticipated to catapult
the global fertility drug and surgery market on upward trajectory in the years
to come. Europe held the second leading position in 2017. It has been studied
in this report that the riding prevalence of sexually transmitted diseases is
responsible for increasing infertility rate in the region. On the other hand,
Asia Pacific fertility drug and surgery market is poised to exhibit immense
developments. Factors such as rising awareness, availability of healthcare
services, etc. are projected to boost revenue growth of the fertility drug and
surgery market in the region over the next few years.
Competitive Dashboard:
The key players participating in the landscape of the global
fertility drug and surgery market are Eli Lilly, Baxter Healthcare Corporation,
Ferring Pharmaceuticals, Inc., Merck & Co. Pharmaceutical Company, Noven
Pharmaceuticalorganon, Inc., Janssen Pharmaceuticals Inc., Personal Products
Company, Pfizer, Inc., Procter & Gamble Pharmaceuticals, and Emd Serono,
Inc. Growth strategies are expected to e executed by these players that are
poised to boost revenue creation in the market over the next couple of years.
Few of these strategies are mergers & acquisitions, collaborations,
partnerships, etc. Investments are also anticipated to be injected in the
future trajectory of the fertility drug and surgery market for gaining edge
over competitors.
Market Insights
The global dental CAM milling market is highly modest.
Market Research Future Reports published its latest reports on global The
Dental CAM Milling Machine Market is expected to reach USD 1,987.29 Million by
2030 at 9.30% CAGR during the forecast period 2022-2030. The market is at
a position to sustain its intense competition and introducing many
opportunities in the future timeline. To be at the same pace of growth and
market position, the key players are continually executing various strategies
such as mergers, acquisitions, partnerships, etc. to make the market rise high
and garner tremendous valuation in the coming years.
Global Dental CAM Milling Market: Drivers & Trends
The main factors responsible for the growth of global dental
cam milling machine market trends are accounted as high adoption of CAD/CAM
systems in the dentistry, that resulted in the increased usage of CAM milling
machines, growing ability to process different dental materials such as
zirconia, acrylic, wax, metal and others with high accuracy and precision. With
that, more factors supported behind the growth of the market, which is
accounted to be the growth of dental service organizations, development of new
dental restorative materials, patient-customized treatment approach, and
increasing cosmetic dentistry treatments.
Furthermore, the rise of numerous dental disorder cases,
increase of elderly population and surge in dental disorders that lead to tooth
deformations and technological innovation in dentistry are the factors that are
catering to the global dental milling machines market substantially. Besides,
more factors such as a surge in preference for corrective dental surgeries is
expected to augment the global dental milling machines market in the next few
years.
Dental CAM Milling Market Segmentation
According to the reports published by MRFR, the global
dental milling machines market has been segmented by type, application, and
end-user.
By the mode of type, the market includes ilab scale milling
machines and office scale milling machines.
By the node of application, the market includes crowns,
dentures, bridges, veneers, and inlays / onlays.
By the mode of end-user, the market has been categorized as
a dental laboratory, dental clinic, and research/academic institutes.
Regional Outlook
On a geographical note, the global dental
milling machines market report has covered the main regions of Europe,
North America, Asia Pacific, and the Middle East & Africa.
Among these, Europe has recorded and garnered the largest
share of the market owing to the early adoption of novel technologies in this
region. The newly advanced technology and dental hygiene witnessed in the
region are likely to boost the extension of the dental CAM milling machine
market in the next couple of years.
Whereas, North America is at the second position of the
global dental CAM milling machine market during the forecast period. Factors
such as the rising burden of dental disorders have projected to lead the growth
of the market in the region. Also, the emphasis of the healthcare providers
towards the progress of dental care services is probable to favor the growth of
the dental CAM milling machine market in the region at a rapid pace.
Lastly, the Asia Pacific region is a highly lucrative market
and is forecasted to record the highest CAGR over the forecasted period. The
rising population of older adults in countries of Asia Pacific is likely to
fuel demand for dental CAM milling machine along with the variations in the
food culture and lifestyle have been prone to boost the growth of the market
across the review period.
Key Players
Market Research Future Reports have sorted some of the key
players in this market are, they are Axsys Incorporated, B&D Dental
Technologies, DATRON AG, Dentsply Sirona, KaVo Dental GmbH, Planmeca OY,
Straumann, and Yenadent Ltd.
About US:
Market Research Future (MRFR), enable customers to unravel the complexity
of various industries through Cooked Research Report (CRR), Half-Cooked
Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research
(CFR), and Market Research & Consulting Services.
Market Analysis
The Cervical
Fusion market trends is anticipated to reach USD 8.10 Billion by 2030 at
3.90% CAGR during the forecast period 2022-2030.The market was valued at USD
1,938.15 million in 2021. Cervical fusion, simply put, is a surgery which helps
in joining selected bones in the cervical spine (neck). This surgery is
generally needed when the discs between each vertebra and the cervical
vertebrae get damaged due to chronic wear-and-tear or an injury. There are
different methods to perform a cervical fusion surgery such as using an
artificial graft made of metals or other polymers or inserting a bone graft for
natural bone regrowth.
Various factors are propelling the cervical fusion market
growth. These factors, as stated by the latest MRFR report, include increasing
prevalence of rheumatoid arthritis and osteoarthritis, growing aging
population, advent of cervical surgery techniques that are technologically
advanced, increasing incidences of cervical disorders, growing cases of cancer
and extensive research and development activities to diagnose and treat cancer,
and increasing funds for healthcare by government organizations.
On the flip side, the high price of treatments,
complications related to the cervical surgery, and the high price of the
diagnostic procedure are factors that may deter the cervical fusion market
growth over the forecast period.
Market Segmentation
The MRFR report provides a complete segmental analysis of
the cervical fusion market report on the basis of end user, surgery, type, and
fusion type.
Based on fusion type, the cervical fusion market is
segmented into posterior fusion, anterior cervical fusion, anterior interbody
fusion, and others. The interbody cervical fusion segment is again segmented
into bone interbody cervical fusion, non-bone interbody cervical fusion, and
others.
Based on type, the cervical fusion market is segmented into
polymeric type, metal type, and others.
Based on surgery, the cervical fusion market is segmented
into open spine surgery, minimally invasive spine surgery, and others.
Based on end user, the cervical fusion market is segmented
into neurology clinics, multispecialty hospitals, orthopedic clinics, and
others.
Regional Analysis
By region, the cervical
fusion market report covers the latest trends and growth opportunities
across Europe, the Americas, the Asia Pacific, and the Middle East and Africa.
Of these, the Americas will lead the market over the forecast period. This is
on account of increasing awareness about preventive care treatments to prevent
spinal deformities and increasing incidences of spinal deformities amongst the
older population.
The cervical fusion market in Europe is predicted to have
the second-largest share in the market over the forecast period. This is on
account of growing incidences of osteoarthritis and rheumatoid arthritis and
rising geriatric population.
The cervical fusion market in the APAC region is predicted
to grow at the fastest pace over the forecast period. This is owing to rapid
expansions by leading players for market development and the growing adoption
of cervical fusion surgeries. Japan is the chief contributor in this region
owing to the remarkable rise in the adoption of cervical fusion surgeries due
to presence of high aging population.
The cervical fusion market in the Middle East and Africa is
predicted to have steady growth during the forecast period. This is on account
of the rising emphasis on R&D activities in the healthcare sector and
extensive growth of healthcare infrastructure.
Key Players
Leading players profiled in the cervical fusion market
report include Shanghai Microport Orthopedics (China), Medacta (US), BAUMER
(Switzerland), Medicrea Technologies UK Ltd (UK), B. Braun Melsungen AG
(Germany), ArthroCare Corporation (US), Exactech, Inc. (US), RTI Surgical, Inc.
(US), AMEDICA Corporation (US), LDR Holding Corporation (US), Integra
LifeSciences Corporation (US), K2M, Inc. (US), Pioneer Surgical Technology
Spine (US), Alphatec Spine, Inc. (US), Zimmer Holdings, Inc. (US), Biomet, Inc.
(US), Orthofix Holdings, Inc. (US), Globus Medical Inc. (US), NuVasive, Inc.
(US), Stryker Corporation (US), Synthes, Inc. (US), DePuy Spine, Inc. (US), and
Medtronic, Inc. (US).
About US:
Market Research Future (MRFR), enable customers to unravel the complexity
of various industries through Cooked Research Report (CRR), Half-Cooked
Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research
(CFR), and Market Research & Consulting Services.
As per the latest published report by Market Research Future
(MRFR), the global forensic swab market is expected to grow at a decent pace in
the forthcoming years of the forecast period. The Forensic
Swab Market trends was valued USD 3630.47 million in 2021 and is expected
to reach USD 6,072.90 million by 2030 at 5.7% CAGR during the forecast period
2022-2030.
The usage of swabs in the forensic industry plays a critical
role in identifying and deciphering various genetic samples. Swabs are
considered as one of the most important tools for the collection of laboratory
samples. The growing adoption of Deoxyribonucleic acid (DNA) forensics and the
proliferating usage of laboratory services across hospitals as well as
independent agencies is anticipated to steer the forensic swab market towards
growth during the review period. Also, the global market for forensic swabs is
also forecasted to be accelerated by the favorable support from the government
and the rising levels of demand in the forthcoming years. Due to presence of
various notable and prominent players, the market is expected to garner notable
development in the coming years.
Market Segmentation
The global forensic swab market segmentation is based in
terms of type, end users, and type of swap shafts.
By type, the market comprises of foam, flocked, and cotton
tips. As per the last market study in 2017, the foam segment spearheaded with
the maximum share. The cotton swabs segment is expected to grow with the highest
growth rate during the forecast period.
By types of swab shaft, the market includes wood stick
shaft, polystyrene shaft, and others. As per the last conducted study of the
market, the polystyrene shaft segment held the top position in the global standings
in this category. The segment is also expected to garner the highest CAGR
during the assessment period.
By end-users, the market segments into hospitals, forensic
science laboratories, and others. The forensic science laboratories segment
held the leading position in this market category as per the last study. The
segment is further expected to continue its leading position in the forthcoming
years of the forecast period.
Regional Analysis
The global forensic
swab market report is regionally segmented into regions like the Americas,
Europe, Asia Pacific, and the Middle East and Africa.
The Americas hold the dominant share and shoulders a massive
portion of the global market. The Americas hold the largest share due to
factors like growing crime cases, increasing number of forensic labs, and
various samplings of blood. The region is expected to hold onto its dominant
position and lead the market standings in the forthcoming years. Additionally,
the expanding number of forensic labs and a rising number of microbiological
tests and hospitals also help drive the market in this region.
The European region hold the second largest share in the
market as per the last conducted study in 2017. The region is poised to grow in
the forthcoming years due to growth in the number of hospitals, research labs,
and the surging number of accident cases.
The Asia Pacific region is anticipated to grow at an annual
rate of 6.1% during the period between 2017 and 2023. The growth in this region
can be attributed to the growing commonness of numerous diseases, an expanding
number of forensic labs, and the imperative need for blood sampling. Lastly,
the Middle East and Africa region is anticipated to witness slow growth and
development due to limited exposure to forensic labs and lack of awareness
concerning forensic swabs.
Competitive Landscape
The global forensic swab market hosts a number of key and
prominent players who are modifying the competitive landscape in a positive
manner. This includes names such as Copan Italia S.p.A., Merck KGaA, Dickinson
and Company, SARSTEDT AG & Co. KG, Puritan Medical Products, Thermo Fisher
Scientific Inc., MWE, Becton, Sirchie, Luna, and MEDTECH Forensics.
About US:
Market Research Future (MRFR), enable customers to unravel the complexity
of various industries through Cooked Research Report (CRR), Half-Cooked
Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research
(CFR), and Market Research & Consulting Services.
Market Analysis
The plastic
surgery and integumentary system procedures market share is expected to
reach USD 4,456.6 Million by 2030 at 6.7% CAGR during the forecast period
2022-2030.Plastic surgery, simply put, is a medical process to restore,
correct, or alter skin on different parts of the body. It is generally
performed as a cosmetic or reconstructive procedure. On the other hand, the
integumentary system, simply put, is an organ framework that includes skin as
well as its extremities, which protects the body against various forms of
damages. It is mostly done for skin cancer, herpes, rabies, athlete’s foot,
rubella, psoriasis, acne, rash, sunburn, and infection.
Various factors are propelling the plastic surgery and
integumentary system procedures market growth. These factors as stated by the
latest Market Research Future report, include growing demand for procedures
especially cryosurgery, chemobrasion, and laser therapy, the influence of
social media, increasing media exposure, increasing rates of obese people,
advancements in technology in surgeries, increasing demand for retaining beauty
and youth, and increasing geriatric population.
On the flip side, the soaring cost of these procedures may
deter plastic surgery and integumentary system procedures market growth over
the forecast period.
Market Segmentation
The MRFR report offers a wide segmental analysis of the on
the basis of plastic surgery and integumentary system procedures market based
on end user, application, operating area, and procedure.
Based on the procedure, the plastic
surgery and integumentary system procedures market outlook is segmented
into skin tests, culture and sensitivity, incisional biopsy, excisional biopsy,
and prefilled syringe biopsy.
Based on the operating area, the plastic surgery and
integumentary system procedures market is segmented into skin, nose, breast,
subcutaneous tissue, and eyelids.
Based on application, the plastic surgery and integumentary
system procedures market is segmented into augmentation, skin cancer, athlete’s
foot, infection, autograft, allograft, and skin grafts.
Based on the end user, the plastic surgery and integumentary
system procedures market is segmented into research institutes, research
laboratories, and hospitals and clinics.
Regional Analysis
By region, the plastic surgery and integumentary system
procedures market report covers the latest trends and growth opportunities
across Europe, North America, the Asia Pacific, and the Middle East and Africa.
Of these, North America will dominate the market over the forecast period.
Factors pushing the growth of the plastic surgery and integumentary system
procedures market in the region include growing demand for cosmetic procedures,
highest expenditure by government sectors on the healthcare sector, consumers
changing lifestyle, growing senior population, growing awareness about surgical
procedures, and early adoption of new medical technologies.
The plastic surgery and integumentary system procedures
market in Europe is projected to have the second-largest share during the
forecast period. Factors pushing the growth of the plastic surgery and
integumentary system procedures market in the region include increasing rates
of surgeries owing to changing lifestyles, increasing research and development
activities, and increasing support and funding from the government to the
healthcare sector.
The plastic surgery and integumentary system procedures
market in the APAC region is projected to have a favorable growth during the
forecast period. Factors pushing the growth of the plastic surgery and
integumentary system procedures market in the region include the availability
of high-quality services, budding medical tourism, high access to technology,
and improving healthcare infrastructure.
The plastic surgery and integumentary system procedures
market in the MEA is projected to have a small share during the forecast period
owing to poor medical facilities, lack of technical knowledge, and
underdeveloped healthcare sector.
Key Players
Notable players profiled in the plastic surgery and
integumentary system procedures market report include Scivision Biotech Inc,
Integra Lifesciences, Sanofi, Valeant Pharmaceuticals, Allergan, Merz Pharma,
Galderma, Lumenis, Alma Lasers, Cynosure Inc., and Allergen Inc.
About US:
Market Research Future (MRFR), enable customers to unravel the complexity
of various industries through Cooked Research Report (CRR), Half-Cooked
Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research
(CFR), and Market Research & Consulting Services.
Facial paralysis is a restriction of the
facial movement due to nerve damage. Facial nerve paralysis is characterized by
unilateral facial weakness. Some other symptoms include loss of taste,
hyperacusis, and decreased salivation and tear secretion.
Asia Pacific is the fastest growing market
for facial paralysis whose growth is attributed to the rising population and
increasing standard of living. Additionally, the increasing healthcare spending
and the improved standard of living are likely to drive the growth of the
market. India and China are the major contributors to the market growth due to
the rapid development of healthcare infrastructure in these regions and the
increasing demand for diagnostic services.
The global facial
paralysis market Trends is expected to register a CAGR of 6.5% during the
forecast period.
Key Players
Some of the key players in the facial
paralysis market are, Boston Scientific, BioControl Medical, Cerebomed,
Cyberonics, Astellas Pharma Inc., Sucampo Pharmaceuticals, Inc., and Novartis
AG, among others.
On the other hand, the Middle East and
Africa is expected to witness a gentle growth due to limited access to the
healthcare industry and affordability issues among the population. In the
Middle East, the growth of the market is driven by the increasing availability of
new and advanced diagnostic and treatment methods for various chronic diseases.
Segmentation
The global facial paralysis market is
segmented on the basis of treatment, diagnosis, type, and end-user.
On the basis of type, the market is
segmented into, Ramsay Hunt Syndrome, facial erythema, Bell’s Palsy, and Lyme
Disease.
On the basis of diagnosis, the market is
segmented into electromyography, computerized tomography, and magnetic
resonance imaging.
On the basis of treatment, the market
is segmented into medications, physical therapy, and surgery.
On the basis of medication, the
market is further sub-segmented into corticosteroids and antiviral drugs.
On the basis of end-user, the market is
segmented into hospitals and clinics, specialty centers, and research centers.
Regional Analysis
The Americas dominates the global facial
paralysis market Research Report owing to increasing cardiovascular
disorders, which eventually leads to the increasing patient population.
Additionally, increasing cardiovascular disorder rate is likely to enhance the
growth of facial paralysis in the North American region. According to the
American Heart Association, 31% of the deaths in the U.S. were due to
cardiovascular disorders. Similarly, in 2015, around USD 3.2 trillion were
spend in healthcare expenditure in the U.S according to the Center for Disease
Control and Prevention. Similarly, in 2015, 1.3% of the U.S. adults were
diagnosed with inflammation of facial nerves.
Europe accounts for the second largest
market due to increasing cardiovascular disorders and increasing infections.
Additionally, the increasing government support and improving healthcare infrastructure
along with increasing facial inflammations are driving the growth of the facial
paralysis market in Europe. For instance, Eurostat estimated that over 19.2% of
the population in Europe was aged 65 and above. This increasing older
population is likely to lead to the increasing patient population. These
factors are likely to drive the growth of the facial paralysis market.
About US:
Market Research Future (MRFR), enable customers to
unravel the complexity of various industries through Cooked Research Report
(CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R),
Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Gout
Market Overview and analysis By Type, By Treatment, By Diagnosis And By End-User Global Forecast Till 2030. The
gout market is anticipated to reach USD 4162.5 Million by 2030 at 11.75% CAGR
during the forecast period 2022-2030, which has been marked as the forecast
period by Market Research Future (MRFR) in the published report. The report
also includes several factors that can make sure the market would grow in the
coming years. Gout can be described as a type of arthritis, which is caused by
higher uric acid levels in the blood. The disease can be triggered by high
blood pressure, high cholesterol, and medications that can spike the presence
of uric acid in the blood. Obesity, diet containing a high amount of red meat,
consumption of alcohol and smoking can trigger symptoms of gout.
The market is getting better thrust from
factors like growing elderly population, transforming lifestyle that includes
more sedentary time, advents of better treatment facilities, and government
initiatives. However, lack of awareness can make this growth daunting in the
coming years.
Competitive Landscape:
The gout market is having a strong influx
of various new players who are giving tough competition to the existing market
bigshots. These players are launching their own types of market strategies to
make sure that they get good mileage from the market. Their strategic moves
often include mergers, new launches, acquisitions, investment, and others. MRFR
got these changes recorded in the report to get a closer view of how the market
is shaping up. These players are Savient Pharmaceuticals, Takeda Pharmaceutical
Company Ltd. Merck & Co. Inc., AstraZeneca plc, Astellas Pharma Inc.,
Ardelyx, Inc., and Novartis AG.
Regional Analysis:
The North American gout market has a
notable chance of making progress in the coming years. The regional market is
known for its high expenditure for the research and development sector, which
is triggering an increasing number of medicines that are getting launched every
year. Major countries inspiring changes are the US and Canada. The regional
number of smokers is also quite high, which, along with the high number of
geriatric population, can trigger the expansion of the gout market. High number
of obese people can also open up spaces for such diseases.
Europe’s market is the second-highest as
the regional awareness regarding gout-related problems is quite high. This is
getting fostered by the rising number of elderly people. Advanced treatment
facilities are also getting introduced owing to which a lot of people are
showing interest in getting their disease healed. This is also getting
bolstered by a rising amount of investment.
The Asia Pacific market is going to show
changes in the market as the growing awareness and the massive population is
expected to transform the market dynamics. The demographic conditions are also
going to play in favor of the market. Countries are launching extensive plans
for their healthcare sectors that can influence the gout market growth as well.
China would be the fastest-growing country. Transforming lifestyles are also
going to create space for market expansion.
The Middle East & Africa market may
suffer from the presence of poor economies, lack of awareness, and insufficient
backing from the technological setup. However, the scenario is changing in
countries like the UAE, Dubai, Saudi Arabia, Qatar, and others.
Segmentation:
The global gout
market research reports of MRFR suggests, can be studied on the basis of an
expert segmentation that includes end-user, treatment, type, and
diagnosis. The report focuses on achieving insights from the market and
that has initiated a detailed review of each segment.
By type, the report on the gout market can
be segmented into tophaceous gout and pseudogout. Both these segments are known
for their impact on the market and revenue-generation.
By treatment, the gout market report can be
segmented into medications and self-care. The medication segment includes
Probenecid, Allopurinol, Febuxostat, Diclofenac, Indomethacin, and Ibuprofen.
The self-care segment is getting acknowledged by patients across the world.
By diagnosis, the market report on the gout
industry can be segmented into blood tests, MRI, X-ray, ultrasound, urine test,
CT scan, and others. Growing demand for early diagnosis is expected to set up a
significant scope for these tests to fetch high income.
By the end-user, the market report on the
gout industry comprises specialty centers, hospitals, and homecare. The home
care segment is witnessing a surge as an increasing number of people are opting
for the self-care segment.
About US:
Market Research Future (MRFR), enable customers to
unravel the complexity of various industries through Cooked Research Report
(CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R),
Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Mental health has come into focus due to
changing lifestyles of patients and unhealthy work hours. Mental health
software and devices utilizes the power of information technology to keep a
check on mental or behavioral disorders. The global mental health software and
devices market report by Market Research Future (MRFR) focuses on various
issues plaguing the market as well as efforts by manufacturers.
The mental
health software and devices market share is expected to reach USD 17.2
Billion by 2030 at 16.1% CAGR during the forecast period 2022-2030
Market Outlook
due to the rapid adoption of software by
mental health professionals. Change in health practices due to availability of
patient records and mental health history can lead to effective management of
patients. Collection and analysis of information, elimination of errors, rise
in patient income levels, and demand for effective solutions for management of pharmacies
are mental health are other drivers of the market.
Development of wearables, changing
attitudes of patients and doctors towards information technology, and pressure
on hospitals to reduce operational costs can drive the global mental health
software and devices market. Real-time monitoring of patient health and
provision of advice and medicines via telemedicine can bode well for the market
growth in the coming years.
Competition Outlook
Prominent mental health software vendors
and device manufacturers profiled in the report include Athena Health,
Mindlinc, Mentegram, WRS Health, Kareo, Nextgen Healthcare, ICANotes, Core
Solutions, InSync Healthcare Solutions, Compulink, Allscripts, Nuesoft
Technologies, NextStep Solutions, Valant, Credible Behavioral Health,
Welligent, Raintree Systems, Netsmart, Meditab Software, Orion Health, The Echo
Group, Sigmund Software, IBM, TheraNest, Advanced Data Systems, AdvancedMD,
Qualifacts, McKesson Corporation, iSalus Healthcare, and Cerner Corporation.
Regional Analysis
Region-wise, the global market comprises
North America, Middle East & Africa (MEA), Asia Pacific (APAC), and Europe.
North America accounted for the largest
market led by the U.S. due to focus on mental health by governments. According
to the American Psychological Association in 2019, the number of young U.S.
citizens with an increase of mental health disorders has risen due to shift in
mood disorders. Other drivers include rapid adoption of technology and
development of healthcare infrastructure by governments.
Europe is the second largest region of the
market driven by large number of burnout cases and mental health issues of
employees. Governments in the region have developed a common platform for
collection of mental health issues and records of patients for implementation
of good policies as well as welfare schemes. On the other hand, the APAC region
is expected to exhibit the fastest growth rate during the forecast period due
to being driven by economies of China, India, and Japan. International brands
in the region are giving mental health insurance for preventing burnouts and
reducing stress in the workplace.
Segmentation Analysis
the global mental
health software and devices market insights is segmented on the basis of
solution, deployment, end users and regions.
By component, the market has been segmented
by software and devices. The software has been sub-segmented into web based and
standalone software.
By functionality, the market has been
segmented by clinical, administrative, financial and others. The clinical
segment has been categorized into tele-health, electronic health records
(EHRs), E-prescribing, clinical decision support, health management, and
others. The administrative has been sub segmented into information management,
scheduling, workforce management, and others.
The financial has been sub segmented into
accounting, revenue cycle management, business intelligence, and others.
About US:
Market Research Future (MRFR), enable customers to
unravel the complexity of various industries through Cooked Research Report
(CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R),
Continuous-Feed Research (CFR), and Market Research & Consulting Services.